From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialty Care>
  3. HIV/AIDS>
  4. Archives

HIV/AIDS: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

 to   
Items 1-10 of 1632 are shown

Cognitive-Behavioral Stress Management Shows Mixed Results for HIV-Infected Patients

  • Summary and Comment
  • Subscription required

In a randomized, controlled trial in Switzerland, cognitive-behavioral stress management was associated with improvements in quality of life and psychological well-being but not in clinical markers of HIV infection.

Non–AIDS-Defining Cancer in HIV-Infected Patients

  • Summary and Comment
  • Subscription required

In a large urban cohort, non–AIDS-defining cancers have become more common than AIDS-defining ones.

Low CD4-Cell Counts — Not Just About OI Risk

  • Summary and Comment
  • Free

In a cohort of patients receiving ART, lower CD4-cell counts increased the risk not only for AIDS-defining conditions but also for non–AIDS-defining disease.

Resistance: What You Don’t Know — Can It Hurt You?

  • Antiretroviral Rounds
  • Free

Two experts weigh in on whether to switch regimens in a patient with evidence of triple-class resistance.

Does Viral-Load Testing Reduce Drug Resistance in Resource-Poor Settings?

  • Summary and Comment
  • Free

Despite viral-load testing, high levels of drug resistance at first virologic failure were found in KwaZulu-Natal, South Africa.

Cefixime Tablets Available in the U.S. Again

  • Drug Watch
  • Subscription required

Cefixime tablets (Suprax; 400 mg) are now available in the U.S. for the first time since 2002. Cefixime is the only CDC-recommended oral treatment for . . .

Caution Urged When Combining Lopinavir/Ritonavir and Rosuvastatin

  • Summary and Comment
  • Subscription required

In a pharmacokinetic study involving 20 healthy volunteers, coadministration of lopinavir/ritonavir and rosuvastatin significantly increased rosuvastatin levels yet attenuated the LDL-lowering effect of the drug; one study participant experienced a grade 4 elevation in creatinine phosphokinase levels.

Both Fish Oil and Fibrates Reduce Triglyceride Levels

  • Summary and Comment
  • Subscription required

Both fish oil and fenofibrate safely reduce elevated triglyceride levels in HIV-infected patients receiving ART.

Rapid ART Scale-Up Needed in South Africa

  • Summary and Comment
  • Subscription required

A mathematical model to estimate the effect of different antiretroviral scale-up scenarios suggests that rapid scale-up is critical if universal access is to be achieved during the next 5 years for all people in need of treatment.

Emergence of the K65R Mutation with NNRTI-Based Regimens

  • Summary and Comment
  • Subscription required

In the Swiss HIV Cohort Study, emergence of the K65R mutation was significantly associated with tenofovir-containing regimens that were anchored by NNRTIs rather than by PIs.

Items 1-10 of 1632 are shown
 to   
Copyright © 2008. Massachusetts Medical Society. All rights reserved.